Prospective risk of stillbirth and neonatal complications in twin pregnancies: systematic review and meta-analysis by Cheong-See, F et al.
Prospective risk of stillbirth and neonatal complications in twin
pregnancies: systematic review and meta-analysis.
Cheong-See, F; Schuit, E; Arroyo-Manzano, D; Khalil, A; Barrett, J; Joseph, KS; Asztalos, E;
Hack, K; Lewi, L; Lim, A; Liem, S; Norman, JE; Morrison, J; Combs, CA; Garite, TJ; Maurel,
K; Serra, V; Perales, A; Rode, L; Worda, K; Nassar, A; Aboulghar, M; Rouse, D; Thom, E;
Breathnach, F; Nakayama, S; Russo, FM; Robinson, JN; Dodd, JM; Newman, RB;
Bhattacharya, S; Tang, S; Mol, BWJ; Zamora, J; Thilaganathan, B; Thangaratinam, S; Global
Obstetrics Network (GONet) Collaboration,
 
 
 
 
 
(c) The Authors, 2016
 
 
For additional information about this publication click this link.
http://qmro.qmul.ac.uk/xmlui/handle/123456789/15542
 
 
 
Information about this research object was correct at the time of download; we occasionally
make corrections to records, please therefore check the published record when citing. For
more information contact scholarlycommunications@qmul.ac.uk
1 
 
Prospective risk of stillbirth and neonatal complications in twin pregnancies: A 
systematic review and meta-analysis  
 
 
Fiona Cheong-See 
Clinical Research Fellow  
Women’s Health Research Unit, Barts and the London School of Medicine and 
Dentistry, Queen Mary University of London, 58 Turner Street, United Kingdom E1 
2AB 
 
Ewoud Schuit 
Postdoctoral Research Fellow 
Julius Centre for Health Sciences and Primary Care, University Medical Centre 
Utrecht, Utrecht, The Netherlands 
Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam, The 
Netherlands 
Stanford Prevention Research Center, Stanford University, 1265 Welch Rd, Palo Alto, 
Stanford, CA 94305  
 
David Arroyo-Manzano 
Biostatistician 
Clinical Biostatistics Unit, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 
Ctra. Colmenar Viejo, km. 9100 28034, Madrid, Spain 
 
Asma Khalil 
Consultant Obstetrician 
Fetal Medicine Unit, St George’s Healthcare NHS Trust, London, United Kingdom 
SW17 0QT 
 
Jon Barrett  
Senior Scientist 
Evaluative Clinical Sciences, Women & Babies Research Program, Sunnybrook 
Research Institute, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada 
 
KS Joseph  
Professor of Obstetrics & Gynaecology 
Department of Obstetrics & Gynecology, University of British Columbia, 1190 Hornby 
Street - 4th Floor, Vancouver, BC Canada V6Z 2K5 
 
Elizabeth Asztalos  
Associate Professor 
Department of Newborn & Developmental Paediatrics, Women & Babies Research 
Program, Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Toronto, ON M4N 
3M5, Canada 
 
Karien Hack  
MD and PhD in Obstetrics & Gynaecology 
2 
 
Department of Gynaecology and Obstetrics, Diakonessenhuis, Bosboomstraat 1 
3582 KE Utrecht, The Netherlands 
 
Liesbeth Lewi  
Assistant Professor in Obstetrics & Gynaecology 
Department of Obstetrics-Gynecology, University Hospitals, Herestraat 49  
3000 Leuven, Belgium 
Department of Development and Regeneration: Pregnancy, Fetus and Neonate, KU 
Leuven, Belgium 
 
Arianne Lim  
Gynaecologist 
Department of Obstetrics & Gynaecology, Academic Medical Center, Meibergdreef 9, 
1105 AZ Amsterdam, The Netherlands  
 
Sophie Liem  
MD in Obstetrics & Gynaecology 
Department of Obstetrics & Gynaecology, Academic Medical Centre, Meibergdreef 9, 
1105 AZ Amsterdam, The Netherlands 
 
Jane E Norman   
Professor of Maternal and Fetal Health 
University of Edinburgh MRC Centre for Reproductive Health, The Queen’s Medical 
Research Institute, Edinburgh, United Kingdom EH16 4TY 
 
John Morrison  
Professor of Obstetrics & Gynaecology and Pediatrics 
Department of Obstetrics & Gynecology, University of Mississippi Medical Center, 
Jackson, USA 
 
C Andrew Combs  
Associate Director of Research 
Obstetrix Collaborative Research Network, The Center for Research, Education and 
Quality, Mednax National Medical Group, 1301 Concord Terrace, Sunrise, Florida 
33323, USA 
 
Thomas J Garite  
Professor Emeritus of Obstetrics & Gynaecology, University of California Irvine, Irvine, 
California 92697 USA 
Director of Research & Education, Obstetrix Collaborative Research Network, The 
Center for Research, Education and Quality, Mednax National Medical Group, 1301 
Concord Terrace, Sunrise, Florida 33323, USA 
 
Kimberly Maurel  
Associate Director 
3 
 
Obstetrix Collaborative Research Network, The Center for Research, Education and 
Quality, Mednax National Medical Group, 1301 Concord Terrace, Sunrise, Florida 
33323, USA 
 
Vicente Serra  
Professor of Obstetrics & Gynaecology 
Maternal-Fetal Medicine Unit, Instituto Valenciano de Infertilidad, University of 
Valencia, Spain; Department of Obstetrics & Gynaecology, Faculty of Medicine, 
University of Valencia, Jefe Servicio Obstetricia Hospital U P La FE, Torre F, planta 
3a, Bulevar Sur s/n 46026 Valencia, Espana 
 
Alfredo Perales  
Professor of Obstetrics & Gynaecology 
Department of Obstetrics, University Hospital La Fe, Valencia, Calle Fernando Abril 
Martorell, 106, 46026 València Spain; Department of Obstetrics & Gynaecology, 
Faculty of Medicine, University of Valencia. 
 
Line Rode  
Senior Resident  
Center of Fetal Medicine, Department of Obstetrics, Copenhagen University Hospital, 
Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark  
 
Katharina Worda  
Specialist in Obstetrics & Gynaecology 
Department of Obstetrics & Gynecology, Medical University of Vienna, Spitalgasse 23, 
1090 Wien, Austria 
 
Anwar Nassar  
Professor of Obstetrics & Gynaecology 
Department of Obstetrics & Gynecology, American University of Beirut Medical Center, 
Riad El Solh, Beirut 1107 2020, Lebanon 
 
Mona Aboulghar  
Professor of Obstetrics & Gynaecology 
The Egyptian IVF Center, Maadi and Department of Obstetrics and Gynecology, 
Faculty of Medicine, Cairo University, Cairo University Road, Oula, Giza, Egypt 
 
Dwight Rouse  
Principal Investigator for the Eunice Kennedy Shriver National Institute of Child 
Health and Human Development Maternal-Fetal Medicine Units (MFMU) Research 
Network and Professor of Obstetrics & Gynaecology 
Department of OB/GYN, Women and Infants Hospital, Brown University Women and 
Infants Hospital, 101 Dudley Street, Providence, Rhode Island, 02905 USA 
 
Elizabeth Thom  
Research Professor of Biostatistics & Epidemiology 
4 
 
The Biostatistics Center, George Washington University, 6110 Executive Blvd #750, 
Rockville, MD 20852, USA 
 
Fionnuala Breathnach  
Consultant Obstetrician & Gynaecologist , Senior Lecturer in Maternal Fetal Medicine 
Royal College of Surgeons in Ireland, Rotunda Hospital, Parnell Square, Dublin, 
Ireland 
 
Soichiro Nakayama  
Assistant Professor 
Department of Maternal Fetal Medicine, Osaka Medical Center and Research Institute 
for Maternal and Child Health, 840, Murodocho, Izumi, Osaka, Japan, Zip Code 594-
1101 
 
Francesca Maria Russo  
MD in Obstetrics & Gynaecology 
Department of Obstetrics & Gynecology, University of Milano-Bicocca, Piazza 
dell'Ateneo Nuovo, 1, 20126 Milano, Italy 
 
Julian N Robinson  
Chief of Obstetrics and Associate Professor 
Division of Maternal Fetal Medicine, Department of Obstetrics & Gynecology, 
Brigham and Women’s Hospital, 75 Francis Street, Boston, Massachusetts 02115, USA 
 
Jodie M. Dodd  
Professor of Obstetrics & Gynaecology 
The The Robinson Research Institute, and Discipline of Obstetrics & Gynaecology, The 
University of Adelaide, 72 King William Road, North Adelaide SA 5006, Australia 
 
Roger B Newman  
Professor and Maas Chair for Reproductive Sciences 
Department of Ob-Gyn, Medical University of South Carolina, 165 Cannon St # 503, 
Charleston, South Carolina 29403, USA 
 
Sohinee Bhattacharya 
Senior Lecturer 
University of Aberdeen 
Dugald Baird Centre for Research on Women’s Health, Aberdeen Maternity Hospital, 
Cornhill Road, Aberdeen AB25 2ZL, Scotland 
 
Selphee Tang 
Data Analyst 
Department of Obstetrics and Gynecology, Alberta Health Services, 4th Floor, North 
Tower, Foothills Medical Centre, 1403-29 Street NW, Calgary, Alberta T2N 2T9 
Canada 
 
Ben Willem J. Mol  
5 
 
Professor of Obstetrics & Gynaecology 
Australian Research Centre for Health of Women and Babies, Robinson Institute, The 
University of Adelaide, 72 King William Road, North Adelaide SA 5006, Australia 
 
Javier Zamora  
Head of Clinical Biostatistics Unit, Director of Clinical Epidemiology Research Area 
Clinical Biostatistics Unit, Hospital Ramón y Cajal (IRYCIS), Ctra. Colmenar Viejo, km. 
9100 28034, Madrid, Spain 
CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain 
 
Senior Lecturer 
Women’s Health Research Unit, Barts and the London School of Medicine and 
Dentistry, Queen Mary University of London, 58 Turner Street, London E1 2AB, United 
Kingdom  
 
Basky Thilaganathan* 
Professor and Director of Fetal Medicine 
Fetal Medicine Unit, St George’s Healthcare NHS Trust, London SW17 0QT United 
Kingdom  
 
Shakila Thangaratinam* 
Professor of Maternal and Perinatal Health 
Women’s Health Research Unit, Barts and the London School of Medicine and 
Dentistry, Queen Mary University of London, 58 Turner Street, London E1 2AB, United 
Kingdom  
 
*joint last authors 
 
A Global Obstetrics Network (GONet) Collaboration 
 
Author for Correspondence 
Javier Zamora 
Clinical Biostatistics Unit  
Hospital Ramón y Cajal (IRYCIS)  
Ctra. Colmenar Viejo, km. 9100 28034, 
Madrid, Spain 
Women’s Health Research Unit, Barts and the London School of Medicine and 
Dentistry, Queen Mary University of London, 58 Turner Street, London E1 2AB, 
United Kingdom 
 
E Mail: javier.zamora@hrc.es Ph: +34 913368103 
 
Keywords 
 
Twin pregnancy, monochorionic, dichorionic, stillbirth, neonatal mortality 
 
Word count = 3292 
6 
 
ABSTRACT 
Study question 
What are the risks of stillbirth and neonatal complications by gestational age in 
uncomplicated monochorionic and dichorionic twin pregnancies?  
 
Methods 
We searched Medline, Embase and Cochrane databases (until December 2015) without 
language restrictions for studies of women with uncomplicated twin pregnancies, which 
reported rates of stillbirth and neonatal outcomes at various gestational ages.  We 
excluded pregnancies with unclear chorionicity, monoamnionicity and twin-to-twin 
transfusion syndrome. Meta-analyses of observational studies and cohorts nested within 
randomised studies were undertaken. We computed prospective risk of stillbirth for 
each study at a given week of gestation, and compared with the risk of neonatal death 
amongst deliveries in the same week. We estimated the gestational age-specific risk 
differences for stillbirths and neonatal deaths in monochorionic and dichorionic twin 
pregnancies after 34 weeks of gestation.  
 
Study answer and limitations 
Thirty-two studies (29,685 dichorionic, 5,486 monochorionic pregnancies) were 
included. In dichorionic twin pregnancies beyond 34 weeks (15 studies, 17,830 
pregnancies), the prospective weekly risk of stillbirths from expectant management and 
the risk of neonatal death from delivery were balanced at 37 weeks’ gestation (risk 
difference 1.2/1000; 95% CI -1.3 to 3.6, I2 = 0%). Delay in delivery by a week (until 38 
weeks) led to an additional 8.8 perinatal deaths per 1000 pregnancies (95% CI 3.6 to 
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14.0 /1000, I2 = 0%) compared to previous week.  In monochorionic pregnancies 
beyond 34 weeks (13 studies, 2,149 pregnancies), there was a trend towards increase in 
stillbirths than neonatal deaths after 36 weeks, with an additional 2.5 per 1000 perinatal 
deaths, which was not significant (95% CI -12.4 to 17.4/1000, I2 = 0%). The rates of 
neonatal morbidity showed a consistent reduction with increasing gestational age in 
mono and dichorionic pregnancies, and admission to the neonatal intensive care unit 
was the commonest neonatal morbidity. The actual risk of stillbirth near term may be 
higher than reported estimates due to the policy of planned delivery in twin pregnancies. 
 
Conclusions  
In order to minimise perinatal deaths, delivery should be offered at 37 weeks’ gestation 
in uncomplicated dichorionic twin pregnancies, and considered at 36 weeks in 
monochorionic pregnancies. 
 
Systematic review registration 
PROSPERO CRD420140075382014 
 
Word count = 346 
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INTRODUCTION 
Twin pregnancies are high risk, with a thirteen-fold increase in stillbirth rates in 
monochorionic, and a five-fold increase in dichorionic twins, compared to singleton 
pregnancies.1-3 Uncomplicated twin pregnancies are often delivered early in an attempt 
to prevent late stillbirth. Delivery before term predisposes to prematurity-associated 
neonatal complications.1 Since 2005, the number of patient safety incidents involving 
multiple pregnancies, including unexpected stillbirth and neonatal deaths, has risen by 
419% in UK, and peaked in 2013/14, resulting in payouts of over £90 million.4,5 The 
optimal gestational age for delivery that minimises fetal and neonatal complications in 
twin pregnancies is not known. Current recommendations vary on the timing of delivery, 
starting from 34 until 37 weeks’ gestation in monochorionic,6 and from 37 to 39 weeks 
in dichorionic twin pregnancies.7-10  
 
Women and their partners, clinicians, and guideline makers need robust estimates of 
stillbirth risk from continuing the pregnancy, and neonatal risk from early delivery, to 
decide on the optimal timing of delivery. Existing reviews have focused mainly on 
stillbirth risk without taking into account the neonatal outcomes.11 There are no 
published data on gestation and chorionicity specific perinatal mortality and morbidity 
in twins to guide decision-making on the timing of delivery.12 Furthermore, randomised 
trials on timing of delivery in twins are not adequately powered to provide robust 
estimates of benefit.13,14  
 
We summarised data from individual studies to quantify the prospective risks of 
stillbirth in women with uncomplicated monochorionic and dichorionic twin 
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pregnancies, as well as the risks to the newborn, when delivered after 34 weeks’ 
gestation, and at various gestational ages,.  
 
METHODS 
We conducted the systematic review based on a prospective protocol15 and reported 
according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses 
(PRISMA) guidelines (Appendix 1).16  
 
Identification of studies  
We searched the major electronic databases Medline, Embase and Cochrane Library 
using the NHS Evidence website and Cochrane online library platforms from inception 
until December 2015 for studies on twin pregnancies reporting rates of stillbirth. Search 
terms representing the participants (‘monochorionic’ OR ‘dichorionic’ OR ‘twin 
pregnancy’ OR ‘multiple pregnancy’) were combined with outcome terms (‘stillbirth’ 
OR (‘fetal or foetal or fetus or foetus’ AND ‘death or demise or mortality’)). We 
supplemented this search with an added search for neonatal outcomes in twin 
pregnancies (Appendix 2). We searched the reference lists of included studies. There 
were no language restrictions. Additionally, we contacted individual authors members 
of the collaborative research networks such as Global Obstetric Network (GONet),17 
Evidence Based Medicine Connect (EBM Connect)18, and the Twin pregnancies 
Individual Participant Data (IPD) Meta-Analysis group for relevant data.19  
 
Study selection  
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Two independent reviewers (FCS and ES) selected the studies by a two-stage process. 
In the first stage, the abstracts and titles of citations were assessed for their eligibility. In 
the second stage, we obtained the full texts of the studies that appeared to fulfill the 
inclusion criteria for evaluation.   
 
We included both observational cohort studies and cohorts nested in randomised studies 
on rates of stillbirth or neonatal outcomes in monochorionic and/or dichorionic twin 
pregnancies. We excluded studies with the following characteristics: unclear 
chorionicity, monoamnionicity, unable to exclude twin-to-twin transfusion syndrome in 
fetuses, and outcomes not provided in weekly or two weekly gestational periods.  
 
We defined stillbirth as a baby born without signs of life after the viability age, or any 
other definition used by the authors. Neonatal mortality was defined as neonatal death 
up to 28 days from delivery. For infants born after 34 completed weeks of gestation, we 
considered the following morbidity outcomes to be clinically relevant: need for assisted 
ventilation, respiratory distress syndrome (RDS), septicemia, hypoxic ischaemic 
encephalopathy or neonatal seizures, and admission to the neonatal intensive care unit. 
For preterm infants, born between 26 and 33+6 weeks’ gestation, in addition to the 
above, we assessed the rates of bronchopulmonary dysplasia, necrotising enterocolitis, 
significantly abnormal cranial ultrasound scan (cystic periventricular leukomalacia or 
grade 3 or 4 intraventricular hemorrhage), and retinopathy of prematurity (stages 3 to 5) 
(Appendix 3). 
 
Quality assessment and data extraction 
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Two independent reviewers (FCS and ES) evaluated the quality of the studies by 
investigating separate parameters for the internal validity (the extent to which the 
information is probably free from bias) and external validity (the representativeness of 
the population). 20-22 We evaluated individual parameters such as study design, method 
of sampling, adequacy of follow-up, ascertainment of the outcome, and appropriate 
determination of gestational age, and chorionicity for internal validity. Studies with 
features such as prospective design, consecutive or random recruitment of patients, 
follow-up rates of over 80%, and use of first trimester ultrasound signs to determine 
chorionicity and gestational age were considered to have low risk of bias. Studies 
without these features or with unclear reporting were classified to have high risk of bias. 
We categorised the studies with the following criteria to be highly representative for 
external validity:  clear definition of uncomplicated twin pregnancies, exclusion of 
pregnancies where one or both of the babies were diagnosed antenatally with growth 
restriction or major congenital abnormalities.  Any discrepancies were resolved after 
discussion with a third reviewer (ST).  
 
Analysis 
We undertook separate analyses for risks of stillbirth and neonatal complications in 
monochorionic and dichorionic twin pregnancies in two periods: from 34 weeks’ 
gestation and beyond, and early preterm (<34 weeks) gestation. From 34 weeks 
onwards, we estimated the risks by weekly gestational ages, with the 34-week period 
representing pregnancies entering the 34+0 to 34+6 weeks’ gestation with live fetuses, 
and so forth. For early preterm (<34 weeks) gestation, we estimated risks of outcomes 
by two weekly intervals.  
12 
 
We computed the weekly prospective risk of stillbirth by dividing the number of 
stillbirths observed at that week by the number of women at risk in the same week. For 
a given gestational age, we defined women at risk of stillbirth as those who were still 
pregnant at the beginning of the week. We corrected for deliveries in that week by 
subtracting half the number of women who delivered that week.23 For risk of neonatal 
death, we used a similar approach and divided the number of neonatal deaths observed 
to the number of deliveries at that week.  
 
In pregnancies beyond 34 weeks’ gestation, we assessed the competing risks of 
expectant management versus delivery at a particular gestational age, for each study. 
We defined the risk of perinatal death at a given gestational week as the difference 
between stillbirth and neonatal death risk for deliveries in that week. This provided a 
direct measure of benefit or harm from expectant management vs. immediate delivery 
strategy.  A risk difference ≤ 0 indicates a reduction in risk of perinatal death with 
expectant management at that gestational age, compared with immediate delivery. We 
pooled risk differences from individual studies using a fixed effect model weighted by 
the inverse of its variance. We computed I-squared as an estimation of between-study 
heterogeneity and assumed values lower than 50% as little heterogeneity and I-squared 
greater than 75% as substantial heterogeneity. 
 
We estimated the weekly risk of neonatal outcomes by fitting multi-level random 
effects logistic regression models with gestational age as the unique categorical 
independent variable. The units of the analysis were pregnancies (first level) that were 
clustered within studies (second level of the analysis). We obtained point estimates of 
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the risk of each event by the gestational period along with its corresponding 95% 
confidence interval (CI). We planned prior to analysis to restrict our evaluation up to the 
gestational week for which robust, unbiased data were available.   
 
Sensitivity analysis was planned before analysis to exclude studies involving 
pregnancies complicated by congenital abnormalities, and those with low external 
validity. We assessed publication bias and small studies effect using funnel plots 
representing overall event rate (in logit scale) versus its standard error. We used 
Begg’s24   and Egger’s25 tests to assess funnel asymmetry.  
 
RESULTS 
Identification of studies 
From 2574 citations, we included 32 studies reporting on 35,171 women with twin 
gestations (Figure 1).14,26-53 Eighteen studies provided data on both monochorionic and 
dichorionic,14,28,30,32,34,36,38,40-43,46-49,52,54,55 seven on only monochorionic,27,29,35,37,39,45,51 
and seven on only dichorionic twin pregnancies.26,31,33,44,50,53,56 Twenty-three authors 
provided relevant unpublished data.14,26,28,30-33,36,37,39-41,45-52,54-56  
 
Characteristics and quality of the included studies 
Fifteen studies on dichorionic pregnancies (17,830 women), and 13 on monochorionic 
pregnancies (2,149 women) provided weekly stillbirth data after 34 weeks’ gestation.  
The corresponding neonatal death rates were provided by 13 (n=10,333) studies for 
dichorionic, and 11 (n=1,461) for monochorionic pregnancies. Overall, 14 studies 
excluded pregnancies complicated by fetal growth restriction, and 28 studies excluded 
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pregnancies with major congenital abnormalities. The diagnosis of fetal growth 
restriction and congenital abnormalities were made antenatally. The postmortem 
findings of the stillborn babies were reviewed for evidence of growth restriction in two 
studies. There were no major differences between the studies in the definitions of 
stillbirths, neonatal mortality, and morbidity outcomes (Appendix 3).  
 
The qualities of the studies were adequately representative in 27 (27/32, 84%), and 
inadequately or unclearly representative in 5 (5/32, 16%) (Figure 2).  Fifteen of the 
included studies (15/32) were prospective, and of these 12 (12/32, 38%) were nested 
cohorts in randomised trials. Most studies used random or consecutive sampling 
methods (31/32, 97%), achieved adequate follow-up (26/32, 81%), and had low 
ascertainment bias in determining stillbirth outcome (31/32, 97%). Twenty studies had a 
low risk of misclassification bias for gestational age assessment (20/32, 63%), and 
chorionicity determination (25/32, 78%).  
 
Stillbirth and neonatal mortality beyond 34 weeks’ gestation 
Dichorionic twin pregnancies 
The prospective risk of stillbirth was 1.2 per 1000 pregnancies (95% CI 0.7-1.8) at  
34+0-6 weeks, with the corresponding risk of neonatal death of 6.7 per 1000 pregnancies 
(95% CI 3.3 to 13.5) (Table 1).  The risks of stillbirth were significantly lower than the 
risks of neonatal deaths at 34+0-6  (risk difference -5.8/1000, 95% CI  -10.4 to -1.2/1000, 
I2=0%), and 35+0-6 weeks’ gestation (risk difference -5.1/1000, 95% CI -8.7 to -1.6/1000, 
I2=0%). The perinatal risks were balanced at 37+0-6 weeks (risk difference 1.2/1000, 
95% CI -1.3 to 3.6/1000, I2=0%), beyond which the stillbirth risks (10.6, 95% CI 7.1 to 
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15.3) significantly outweighed the neonatal death risk (1.5/1000, 95% CI 0.7 to 3.3) 
from delivery (risk difference 8.8/1000, 95% CI 3.6 to 14/1000, I2=0%) (Figure 3). 
Analysis by excluding fetuses with congenital abnormalities showed results similar to 
the main analysis (Appendix 6). Exclusion of studies with low external validity showed 
a trend towards increased stillbirth risk than neonatal death beyond 370+6 weeks, which 
was not statistically significant.  
 
Monochorionic twin pregnancies 
At 34 weeks, the prospective risk of stillbirth and neonatal mortality rates in 
monochorionic pregnancies were 0.9 (95% CI 0.1 to 3.4) and 12.1 (95% CI 4.2 to 34.3) 
respectively. The risks of neonatal death were higher than stillbirth at 34+0-6 (risk 
difference -15.6/1000, 95% CI -40.4 to 9.1/1000, I2=0%) and 35+0-6 weeks (risk 
difference -2.4/1000, 95% CI -17.6 to 12.8/1000, I2=0%) which were not statistically 
significant (Figure 3). Beyond 36+0-6 weeks, we observed a trend where the risk of 
stillbirth (9.6/1000, 95% CI 3.9 to 19.7) was higher than neonatal deaths (3.6/1000, 
95% CI 1.2 to 11.1) with a risk difference of 2.5/1000 (95% CI -12.4 to 17.4/1000, 
I2=0%). Sensitivity analysis by excluding studies with congenitally malformed fetuses 
(Appendix 6), and studies with low external validity showed similar findings.  
 
All analyses were restricted until 38 weeks for monochorionic twin pregnancies and 
until 39 weeks for dichorionic twin pregnancies due to the non-availability of robust 
data beyond this period. 
Neonatal morbidity beyond 34 weeks’ gestation 
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We observed a consistent and significant reduction in the rates of assisted ventilation, 
respiratory distress syndrome, admission to neonatal intensive care unit, and 
septicaemia with increasing gestational age in babies of both monochorionic and 
dichorionic twin pregnancies (Table 2).  Neonatal Intensive Care Unit (NICU) 
admission in the infants was the commonest complication in monochorionic and 
dichorionic twin pregnancies.  
 
Stillbirth and neonatal outcomes in early preterm twin pregnancies  
The cumulative risks of stillbirth and risks of neonatal deaths by two weekly gestational 
periods in early preterm twin pregnancies (between 26 to 33 weeks and 6 days 
gestation) are provided in Appendix 4. Early preterm neonatal outcomes in two-weekly 
epochs are shown in Appendix 5. Neonatal morbidity reduced with increasing 
gestational age in all twin pregnancies. The commonest neonatal complications were 
respiratory distress syndrome, septicaemia, admission to the neonatal intensive care unit 
(NICU) and need for assisted ventilation, in both monochorionic and dichorionic 
pregnancies. 
 
Publication bias and small studies effect 
Funnel plots found a slight asymmetry for stillbirth outcome in monochorionic 
pregnancies. Smaller studies tended to show lower stillbirth rates than larger studies 
(Begg’s test p-value = 0.139 and Egger’s test p-value = 0.014). We did not find 
evidence of publication bias for other outcomes 
 
DISCUSSION 
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Our study provides comprehensive estimates comparing risks of stillbirth, and neonatal 
mortality at various gestational ages, which is required for planning delivery in 
uncomplicated twin pregnancies. In dichorionic twin pregnancies the perinatal risks are 
balanced until 370+6 weeks’ gestation, and until 360+6 in monochorionic pregnancies, 
with higher risks of stillbirths than neonatal deaths beyond this gestation. 
We have undertaken the largest and most robust systematic review to-date on stillbirths 
and neonatal outcomes in twin pregnancies. In addition to the stillbirth risk at each 
gestational week, we provided risk estimates of the other equally important 
consequence of early delivery, namely neonatal death. Ours is the first review to 
provide chorionicity and gestational age-specific neonatal morbidity estimates in twin 
pregnancies. All the included studies were relatively recent and published within the last 
ten years. The sharing of unpublished aggregate and individual patient data by authors 
enabled us to provide our findings in clinically relevant weekly intervals. We chose the 
gestational timeframes to reduce bias from varied lengths of follow up.  We minimised 
heterogeneity by excluding studies without clear details on twin-to-twin transfusion 
syndrome. Our sensitivity analyses allowed us to assess the risks in pregnancies not 
complicated by congenital malformation, and by fetal growth restriction. 
 
Our findings were limited by the policy of planned delivery beyond 37 and 38 weeks 
gestation in most studies. This reduced the available sample size near term, particularly 
in monochorionic pregnancies, and may have underestimated the risk of stillbirth in the 
last epoch. Although we observed an increased prospective risk of stillbirth than 
neonatal death beyond 36 weeks in monochorionic pregnancies, the differences were 
not statistically significant. This was due to the gradual decline in the number of 
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pregnancies available for analysis, which may be attributed to the policy of elective 
delivery near term.  Most studies did not provide details on whether stillbirth was 
diagnosed antenatally or at birth. However, given the policy of regular ultrasound for 
fetal monitoring in most units, we expect the interval between diagnosis and delivery to 
be small. The variation observed in the clinical management of twin pregnancies and 
neonatal care after delivery between centres may also have influenced the outcomes.57 
The small study effects that we observed for stillbirth outcomes in monochorionic 
pregnancies could be attributed to selective reporting or publication of data from centres 
showing good outcomes and small sample sizes. We ensured that all data were available 
from 34 weeks for women in randomised trials, but it is possible that women with early 
stillbirth would not be in the analysis.  
 
We have taken a pragmatic approach by including all twin pregnancies not complicated 
by twin-to-twin transfusion syndrome. We were not able to provide separate estimates 
for individual causes of neonatal mortality, or for elective and emergency deliveries. 
The results did not vary after excluding pregnancies complicated by fetal growth 
restriction, one of the main indications for emergency delivery. We only focused on 
short-term neonatal morbidity due to paucity of data.58,59 We provided the risk estimates 
per pregnancy and not per fetus, as it is likely that mothers would consider the 
prospective risk of death in either of their fetuses in utero or after delivery to be equally 
important. However, this limited our ability to distinguish between those pregnancies 
with a single or double adverse outcome.  
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Primary studies,13,14,27,37,60 systematic reviews,11 and guideline bodies7,61 were limited in 
their interpretation of evidence on the timing of delivery in twin pregnancies due to 
paucity of data and methodological inadequacies. Firstly, they compared the risks of 
stillbirth in twin pregnancies at various gestational weeks with those at (or) near term, 
without considering the inherent longitudinal design with women repeatedly observed 
during the pregnancy.62 Secondly, some studies made risk estimations using survival 
analysis (Kaplan-Meier method). Delivery was not considered as a competing event for 
the outcome of stillbirth, and may have overestimated the risk.63 Thirdly, studies did not 
provide gestational age-specific pooled estimates for significant neonatal morbidity.11,64 
Fourthly, existing recommendations on the timing of delivery are based on gestational 
age-specific stillbirth risk, and do not formally take into account the benefit gained by 
reducing neonatal deaths.11,65 Finally, the risks of fetal death in twins were not assessed 
beyond 36 weeks gestation, and the rationale behind the choice of the gestational ages 
for elective delivery is not clear.7 Other large epidemiological studies on perinatal 
outcomes in twins were limited by the lack of detail regarding the chorionicity, and the 
definition of uncomplicated monochorionic pregnancies.66,67  
 
Some current recommendations offer expectant management of uncomplicated 
dichorionic twin pregnancies until 380+6.6,8 Based on our findings, this poses a risk of 
additional 8.8 perinatal deaths compared to delivery a week earlier. Although the 
estimates for monochorionic pregnancies are not precise, the current policy of delivery 
at 340+6 weeks as advocated in some guidelines6,8 has the potential to incur high 
perinatal deaths. The information on risks provided in twin pregnancies will 
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complement the ongoing national and international efforts in the to reduce the rates of 
stillbirths68  and unexpected neonatal complications in babies born near term.  
 
With a tenth of all twin pregnancies delivering before 32 weeks, our estimates on early 
preterm neonatal mortality and morbidity provide crucial information to counsel 
mothers at risk of early preterm delivery.69-71 Our work has fulfilled the unmet needs in 
this area, where current estimates on the predicted probability of survival of newborns, 
especially early preterm twins, are based on extrapolated data from small samples, and 
do not take into account the effects of chorionicity.12 Although we did not incorporate 
economic evaluation in our review, avoiding early delivery has the potential for huge 
savings to the healthcare system, by up to $70,000 per infant.60 
 
The feasibility of a definitive randomised trial on optimal timing of delivery in twin 
pregnancies is limited, given the huge numbers needed to assess outcomes.13,14 
Individual patient data (IPD) meta-analysis will allow us to assess the effect of factors 
such as monitoring of the fetuses, level of newborn care, and mode of delivery on 
outcomes. There is a need to study the effects of delivery before 37 weeks and the loss 
of a co-twin in monochorionic pregnancies on long-term infant 
neurodevelopment.59,72,73  
 
CONCLUSION 
Delivery should be offered to mothers with dichorionic pregnancies at 37 weeks, and 
considered at 36 weeks in monochorionic twin pregnancies, to minimise the risk of 
perinatal deaths near term. Our estimates of fetal and neonatal outcomes at various 
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gestational ages in twin pregnancies should be taken into account while making 
decisions on timing of delivery.  
 
 
WHAT IS ALREADY KNOWN 
1. Twin pregnancies are at higher risk of stillbirth than singleton pregnancies 
2. Stillbirth risk increases with advancing gestational age in uncomplicated 
monochorionic and dichorionic twin pregnancies  
3. The risk of neonatal mortality and morbidity reduces with increasing 
gestational age in singletons 
 
WHAT THIS STUDY ADDS 
1. Women with dichorionic twin pregnancies should be offered delivery at 37 
weeks’ gestation to prevent significant increase in stillbirths from expectant 
management compared to neonatal deaths from delivery.  
2. In monochorionic twin pregnancies delivery should be considered at 36 
weeks’ gestation due to the potential increased risks of stillbirths than 
neonatal deaths. 
3. Gestation specific risks of neonatal outcomes in early preterm twin 
gestations that are provided will aid in the counselling of mothers at risk of 
early preterm delivery 
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